ATE108326T1 - Wässerige desmopressin-cmc enthaltende arzneizubereitung. - Google Patents

Wässerige desmopressin-cmc enthaltende arzneizubereitung.

Info

Publication number: ATE108326T1
Authority: AT; Austria
Prior art keywords: cmc; desmopressin; medication containing; aqueous; containing desmopressin
Prior art date: 1989-01-30

Application number

AT90300622T

Other languages

English (en)

Inventor

Uwe Schrell

Original Assignee

Corint Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-30

Filing date

1990-01-22

Publication date

1994-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26974270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE108326(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-01-22 Application filed by Corint Ltd filed Critical Corint Ltd

1994-07-15 Application granted granted Critical

1994-07-15 Publication of ATE108326T1 publication Critical patent/ATE108326T1/de

Links

229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
108010000437 Deamino Arginine Vasopressin Proteins 0.000 abstract 2
NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 abstract 2
229960004281 desmopressin Drugs 0.000 abstract 2
229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT90300622T 1989-01-30 1990-01-22 Wässerige desmopressin-cmc enthaltende arzneizubereitung. ATE108326T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30486289A	1989-01-30	1989-01-30
US43575389A	1989-11-14	1989-11-14

Publications (1)

Publication Number	Publication Date
ATE108326T1 true ATE108326T1 (de)	1994-07-15

Family

ID=26974270

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90300622T ATE108326T1 (de)	1989-01-30	1990-01-22	Wässerige desmopressin-cmc enthaltende arzneizubereitung.

Country Status (4)

Country	Link
EP (1)	EP0381345B1 (de)
AT (1)	ATE108326T1 (de)
DE (1)	DE69010518T2 (de)
ES (1)	ES2019025A6 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994007510A1 (en) *	1992-10-02	1994-04-14	Kabi Pharmacia Ab	Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
RU2135204C1 (ru) *	1993-06-29	1999-08-27	Ферринг Б.В.	Составы для назального введения десмопрессина
US6288030B1 (en)	1993-12-22	2001-09-11	Amgen Inc.	Stem cell factor formulations and methods
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
ES2319054B1 (es)	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
US10172911B2 (en)	2013-10-01	2019-01-08	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988005661A1 (en) *	1987-01-30	1988-08-11	Biomed Research Consultants, Limited	Vasopressin-based pharmaceutical compositions

1990
- 1990-01-22 EP EP90300622A patent/EP0381345B1/de not_active Expired - Lifetime
- 1990-01-22 DE DE69010518T patent/DE69010518T2/de not_active Expired - Fee Related
- 1990-01-22 AT AT90300622T patent/ATE108326T1/de not_active IP Right Cessation
- 1990-01-24 ES ES9000213A patent/ES2019025A6/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2019025A6 (es)	1991-05-16
DE69010518D1 (de)	1994-08-18
EP0381345B1 (de)	1994-07-13
EP0381345A1 (de)	1990-08-08
DE69010518T2 (de)	1994-11-03

Similar Documents

Publication	Publication Date	Title
ATE74519T1 (de)	1992-04-15	Waessrige loesung von fettloeslichen wirkstoffen.
DE3868037D1 (de)	1992-03-05	Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69104777D1 (de)	1994-12-01	Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
DE3676235D1 (de)	1991-01-31	Arzneizubereitung mit verzoegerter wirkstoffabgabe.
EP0731712A4 (de)	2005-11-09	Physiologisch stabile butlersäurepräparate, und butlersäuresalze und -derivate als antineoplastische wirkstoff
DE3586713D1 (de)	1992-11-05	Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3671367D1 (de)	1990-06-28	Arzneistoffadsorbate und deren herstellung.
ES2075468T3 (es)	1995-10-01	Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
DK360489D0 (da)	1989-07-20	Produkter indeholdende mikro- eller nanopartikler samt fremgangsmaade til deres fremstilling
DK490788D0 (da)	1988-09-02	Biologisk aktivt middel med kontrolleret, langvarig firgivelse
DE69000881D1 (de)	1993-03-25	2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
ES2136105T3 (es)	1999-11-16	Preparacion farmaceutica y/o cosmetica.
MX9101035A (es)	1992-05-04	Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ES2141208T3 (es)	2000-03-16	Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
IT8821712A0 (it)	1988-08-17	Strutture assorbenti con agente gelificante e articoli assorbenti contenenti tali strutture.
DE3769707D1 (de)	1991-06-06	Therapeutisches system mit geregelter wirkstoffabgabe.
TR23919A (tr)	1990-12-11	Atomize edici meme ve kullanimi.
DE69002034D1 (de)	1993-07-29	Vorrichtung mit gesteuerter wirkstoffabgabe.
DE68902300D1 (de)	1992-09-03	Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FI864164A7 (fi)	1987-04-18	Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
FI891865A7 (fi)	1989-10-21	Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
DE69010518D1 (de)	1994-08-18	Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
FI863159A7 (fi)	1987-04-16	Sydänlääkkeinä käytettäviä heterosyklokarbonyyli- ja asetyylitiatsoloneja.
EP0239644A4 (de)	1987-10-27	Neue physiologisch aktive mittel mit blutkoagulierungsregelnder wirkung.
FR2572932B1 (fr)	1987-01-23	Medicament insoluble administre localement dans l'oreille

Legal Events

Date	Code	Title	Description
1995-02-15	UEP	Publication of translation of european patent specification
1997-10-15	REN	Ceased due to non-payment of the annual fee